Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-24

FDA Approved: XERESE — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

FDA approved a supplemental application for XERESE (acyclovir and hydrocortisone) by Bausch Health US LLC, resulting in labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XERESE (ACYCLOVIR AND HYDROCORTISONE)

Snippet

SUPPL AP for XERESE (ACYCLOVIR AND HYDROCORTISONE)